The Centers for Medicare & Medicaid Services today announced that it will delay indefinitely the payment penalty period of the Appropriate Use Criteria program for advanced imaging services. The program, which was set to potentially go into effect on Jan. 1, 2023, requires imaging provider claims to include additional information regarding the ordering physician’s consultation with clinical decision support tools. The AHA since 2021, through letters to CMS dating back to last June and September, has led a sustained effort to urge delayed enforcement of these provisions until the process can occur efficiently without adding significant administrative burden on providers.

Related News Articles

Headline
Senate Health, Education, Labor, and Pensions Committee Chairman Bill Cassidy, M.D., R-La., today released a report detailing findings from an investigation…
Headline
The AHA April 18 filed friend-of-the-court briefs in three cases in support of Louisiana's 340B contract pharmacy law that prohibits drug companies from…
Headline
A Minnesota state court April 15 dismissed a lawsuit filed by PhRMA challenging the state’s law protecting 340B pricing for contract pharmacy arrangements. The…
Headline
The White House April 15 released an executive order directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription…
Headline
The AHA March 27 made a series of recommendations to the Physician‐Focused Payment Model Technical Advisory Committee to address barriers to participating in…
Headline
The Department of Health and Human Services said its decision to prevent drug companies from implementing a 340B rebate model “was within its statutory…